Company news
Gelteq Limited (NASDAQ:GELS) news
Gelteq Limited news releases on 6ix. Latest, Jun 17, 2026: Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical…
Press releases & updates
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
June 17, 2026
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
June 11, 2026
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
June 3, 2026
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 20, 2026
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
May 12, 2026
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
February 11, 2026
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
January 13, 2026
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program
December 16, 2025
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China
December 9, 2025
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
December 5, 2025
Gelteq to Present at Investor Summit Virtual on December 9, 2025
December 2, 2025
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
November 24, 2025
Gelteq : Annual Report for Fiscal Year Ending June 30, 2025 (Form 20-F)
November 17, 2025
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform
October 23, 2025
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound
October 9, 2025
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
September 12, 2025
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
September 5, 2025
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs
September 3, 2025
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
July 17, 2025
Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner
June 10, 2025
Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand
February 27, 2025
Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC
February 3, 2025
Gelteq Appoints Matthew Jones as Head of Sports Performance
January 23, 2025
Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
December 18, 2024
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
December 16, 2024
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
December 9, 2024
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
December 1, 2024
Gelteq Announces 400,000 Units Enter into Production in November 2024
November 25, 2024
Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business
November 11, 2024
Gelteq Limited Closes US$5.2 Million Initial Public Offering
October 29, 2024
Gelteq Limited Prices US$5.2 Million Initial Public Offering
October 27, 2024